Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

NCT02599402

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution Garran, Australian Capital Territory, Australia
  • Local Institution Camperdown, New South Wales, Australia
  • Local Institution Coffs Harbour, New South Wales, Australia
  • Local Institution Gateshead, New South Wales, Australia
View all 111 locations
View Trial Details
Completed

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

NCT00414765

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations
  • USC/Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

NCT02296112

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

TheraSphere for the Treatment of Liver Metastases

NCT00511862

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +22 more
Locations
  • Northwestern Memorial Hospital, Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • John Hopkins Hospital Baltimore, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Albany Medical Center Albany, New York, United States
View Trial Details
Completed

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

NCT00704730

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
Locations
  • University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States
  • TGEN Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Burbank, California, United States
View all 113 locations
View Trial Details
Completed

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

NCT00118274

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details

Related conditions